EGM
ELTX icon

Engineers Gate Manager’s Elicio Therapeutics ELTX Stock Holding History

Engineers Gate Manager’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Buy
+13,160
New +$127K ﹤0.01% 1976

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Engineers Gate Manager's ELTX Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in Elicio Therapeutics (ELTX) in Q1 2026: 13,160 shares worth $141K. The stake represents ﹤0.01% of the portfolio and ranks #1976 among its holdings.

47 funds tracked by Wall St. Rank hold ELTX as of Q1 2026.

  • Engineers Gate Manager held 13,160 shares of Elicio Therapeutics worth $141K as of Q1 2026.
  • Elicio Therapeutics was a new Engineers Gate Manager position in Q1 2026.
  • Elicio Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1976 holding.
  • 47 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.